98 related articles for article (PubMed ID: 20732914)
1. Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours.
Azoitei N; Pusapati GV; Kleger A; Möller P; Küfer R; Genze F; Wagner M; van Lint J; Carmeliet P; Adler G; Seufferlein T
Gut; 2010 Oct; 59(10):1316-30. PubMed ID: 20732914
[TBL] [Abstract][Full Text] [Related]
2. Tumour angiogenesis as a chemo-mechanical surface instability.
Giverso C; Ciarletta P
Sci Rep; 2016 Mar; 6():22610. PubMed ID: 26948692
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of angiogenesis in tumour.
Zhang R; Yao Y; Gao H; Hu X
Front Oncol; 2024; 14():1359069. PubMed ID: 38590656
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.
Azoitei N; Kleger A; Schoo N; Thal DR; Brunner C; Pusapati GV; Filatova A; Genze F; Möller P; Acker T; Kuefer R; Van Lint J; Baust H; Adler G; Seufferlein T
Neuro Oncol; 2011 Jul; 13(7):710-24. PubMed ID: 21727210
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases.
Wille C; Köhler C; Armacki M; Jamali A; Gössele U; Pfizenmaier K; Seufferlein T; Eiseler T
Mol Biol Cell; 2014 Feb; 25(3):324-36. PubMed ID: 24336522
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase D family kinases: roads start to segregate.
Wille C; Seufferlein T; Eiseler T
Bioarchitecture; 2014; 4(3):111-5. PubMed ID: 24847910
[TBL] [Abstract][Full Text] [Related]
7. A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis.
Armacki M; Joodi G; Nimmagadda SC; de Kimpe L; Pusapati GV; Vandoninck S; Van Lint J; Illing A; Seufferlein T
Oncogene; 2014 Feb; 33(9):1167-80. PubMed ID: 23503467
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase D1 - A targetable mediator of pancreatic cancer development.
Fleming Martinez AK; Storz P
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119646. PubMed ID: 38061566
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer.
Li Z; Liu Y; Guo P; Wei Y
Aging (Albany NY); 2023 Nov; 15(21):12413-12450. PubMed ID: 37938164
[TBL] [Abstract][Full Text] [Related]
10. 3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model.
Pion E; Karnosky J; Boscheck S; Wagner BJ; Schmidt KM; Brunner SM; Schlitt HJ; Aung T; Hackl C; Haerteis S
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954398
[TBL] [Abstract][Full Text] [Related]
11. Chlorinated benzothiadiazines inhibit angiogenesis through suppression of VEGFR2 phosphorylation.
Huwaimel BI; Jonnalagadda S; Jonnalagadda S; Zahra FT; Nocentini A; Supuran CT; Mikelis CM; Trippier PC
Bioorg Med Chem; 2022 Aug; 67():116805. PubMed ID: 35635929
[TBL] [Abstract][Full Text] [Related]
12. Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy.
Li XY; Ma WN; Su LX; Shen Y; Zhang L; Shao Y; Wang D; Wang Z; Wen MZ; Yang XT
Front Cell Dev Biol; 2022; 10():805507. PubMed ID: 35155426
[No Abstract] [Full Text] [Related]
13. Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.
Zhang X; Connelly J; Chao Y; Wang QJ
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807058
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil triggers tumor lethality through altered expression of HSP90 and degradation of PKD2.
Chen L; Liu Y; Becher A; Diepold K; Schmid E; Fehn A; Brunner C; Rouhi A; Chiosis G; Cronauer M; Seufferlein T; Azoitei N
Carcinogenesis; 2020 Oct; 41(10):1421-1431. PubMed ID: 31917403
[TBL] [Abstract][Full Text] [Related]
15. PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway.
Liu Q; Li W; Zhou Y; Jian J; Han S; Liu C; Li W; Zhu X; Ma D; Ji M; Ji C
Onco Targets Ther; 2019; 12():10931-10941. PubMed ID: 31849496
[TBL] [Abstract][Full Text] [Related]
16. Physical plasma-triggered ROS induces tumor cell death upon cleavage of HSP90 chaperone.
Bekeschus S; Lippert M; Diepold K; Chiosis G; Seufferlein T; Azoitei N
Sci Rep; 2019 Mar; 9(1):4112. PubMed ID: 30858416
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase D2: a versatile player in cancer biology.
Azoitei N; Cobbaut M; Becher A; Van Lint J; Seufferlein T
Oncogene; 2018 Mar; 37(10):1263-1278. PubMed ID: 29259300
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.
Plastira I; Bernhart E; Goeritzer M; DeVaney T; Reicher H; Hammer A; Lohberger B; Wintersperger A; Zucol B; Graier WF; Kratky D; Malle E; Sattler W
J Neuroinflammation; 2017 Dec; 14(1):253. PubMed ID: 29258556
[TBL] [Abstract][Full Text] [Related]
20. STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.
Liu Y; Steinestel K; Rouhi A; Armacki M; Diepold K; Chiosis G; Simmet T; Seufferlein T; Azoitei N
Oncotarget; 2017 Sep; 8(44):77474-77488. PubMed ID: 29100402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
